The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Roche/Genentech
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Roche/Genentech
First-line immunochemotherapy for follicular lymphoma in the GALLIUM study: Prognostic value of PET-CT status after long-term follow-up.
 
Tina Nielsen
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Sally Barrington
Speakers' Bureau - Roche; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celleron Therapeutics (Inst); Roche (Inst)
 
Michel Meignan
Honoraria - Roche
Travel, Accommodations, Expenses - Roche
 
Deniz Sahin
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Andrea Knapp
Employment - Roche
 
Anastasiia Kinkolykh
Consulting or Advisory Role - Roche
 
Michael Herold
Research Funding - Roche
 
Wolfgang Hiddemann
Honoraria - Celgene; Janssen; Roche
Consulting or Advisory Role - Celgene; Janssen; Roche
Speakers' Bureau - Celgene; Janssen; Roche
Research Funding - Bayer; Janssen; Roche
Travel, Accommodations, Expenses - Celgene; Janssen; Roche
 
Robert Marcus
No Relationships to Disclose
 
Judith Trotman
Research Funding - Beigene (Inst); celgene (Inst); Janssen-Cilag (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche/Genentech